Jinjin Wang
Beijing, 100049, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Site-specific adaptive nanovesicles for oral insulin delivery.
Journal: Science advances
Published: September 24, 2025
Controlling T cell-tumor cell interaction with a biomimetic physical barrier for cancer immunotherapy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 08, 2025
Critical band-to-band-tunnelling based optoelectronic memory.
Journal: Light, science & applications
Published: September 12, 2024
Conformation Dependent Architectures of Assembled Antimicrobial Peptides with Enhanced Antimicrobial Ability.
Journal: Advanced healthcare materials
Published: May 26, 2023
Targeting vaccines to dendritic cells by mimicking the processing and presentation of antigens in xenotransplant rejection.
Journal: Nature biomedical engineering
Published: April 11, 2023
Gate-Tunable van der Waals Photodiodes with an Ultrahigh Peak-to-Valley Current Ratio.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: January 01, 2023
Navigations of the targeting pathway of nanomedicines toward tumor.
Journal: Expert opinion on drug delivery
Published: August 05, 2022
Lipid-Based Intelligent Vehicle Capabilitized with Physical and Physiological Activation.
Journal: Research (Washington, D.C.)
Published: July 21, 2022
Suppression of cytokine release syndrome during CAR-T-cell therapy via a subcutaneously injected interleukin-6-adsorbing hydrogel.
Journal: Nature biomedical engineering
Published: March 23, 2022
An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccination.
An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccination.
Journal: Nature communications
Published: January 12, 2021
Effect of physicochemical properties on in vivo fate of nanoparticle-based cancer immunotherapies.
Journal: Acta pharmaceutica Sinica. B
Published: October 26, 2020
Proton-driven transformable nanovaccine for cancer immunotherapy.
Journal: Nature nanotechnology
Published: January 20, 2020
Last Updated: 09/26/2026